期刊文献+

2009年8月—2012年8月武警上海市总队医院的中药注射剂致不良反应分析 被引量:6

Analysis on adverse drug reactions induced by Chinese materia medica injections during August, 2009—August, 2012 in Shanghai Armed Police Corps Hospital
原文传递
导出
摘要 目的探讨中药注射剂不良反应的发生率及其临床表现类型,分析武警上海市总队医院中药注射剂发生不良反应的影响因素。方法通过回顾性分析武警上海市总队医院2009年8月—2012年8月发生中药注射剂不良反应的病历,收集中药注射剂不良反应详细病案,使用计量学方法对病案资料进行整理。结果在病例中怀疑中药注射剂不良反应117例,其中男性58例,女性59例;60岁以上患者不良反应发生率最高,为48.72%,且其治愈时间与其他各组相比显著延长(P〈0.05);不良反应发生在用药后10-30 min较多,占41.03%;2种以上药物联合应用时发生不良反应占61.54%;中药注射剂引发不良反应的主要表现为皮肤损害和心血管循环系统症状,其中以皮肤损害比例最高,达55.56%,循环系统症状占23.93%。较严重的不良反应有过敏性休克、喉头水肿、呼吸困难等。造成中药注射剂不良反应构成比最高的为喜炎平注射液69例,占58.97%。结论熟练掌握中药注射剂的不良反应,积极应对不良反应,有利于提高中药注射剂的合理使用水平,提高临床疗效,做到安全、合理用药。 Objective To evaluate the characteristics and patterns of adverse drug reaction(ADR) induced by Chinese materia medica injections(CMMI) in Shanghai Armed Police Corps Hospital.Methods Statistical data from August 2009 to August 2012 were analyzed.The categories of ADR induced by CMMI were statistically analyzed by systematic evaluation and retrospective analysis.Results Cases(117) of ADR were suspected CMMI,58 male and 59 female patients;Elderly(60 years) patients with a higher incidence of ADR,accounting for 48.72%,and the healing time compared with the younger patients was significantly longer(P0.05);ADR mostly occurred in 10—30 min after administration,accounting for 41.03%;Combination therapy accounted for 61.54% of ADR;Xiyanping injection had the highest ratio of ADR(69cases),accounting for 58.97% of the total number of reported ADR.The major ADR were skin damage(55.56%) and circulatory system symptoms(23.93%).The bad responses such as allergic shock,laryngeal edema,and dyspnoea were severe,which were mainly caused by allergy.Conclusion It is useful to improve the level of rational usage of CMMI by mastering ADR of CMMI,so as to improve the clinical efficacy and safety and use the drugs rationally.
出处 《现代药物与临床》 CAS 2013年第5期787-790,共4页 Drugs & Clinic
关键词 中药注射剂 不良反应 回顾性分析 预防 Chinese materia medica injections adverse drug reactions retrospective analysis prevention
  • 相关文献

参考文献18

二级参考文献143

共引文献193

同被引文献63

  • 1刘新峰,徐格林,Guy van Melle,Julien Bogousslavsky.急性缺血性与出血性卒中危险因素的对比研究[J].中华神经科杂志,2005,38(7):421-425. 被引量:42
  • 2任德权,张伯礼.中药注射剂临床应用指南[M].北京:人民卫生出版社,2011.
  • 3药品说明书和标签管理规定 [S]. 2006.
  • 4Jung K, LePendu P, Chen W S, et al. Automated detection of off-label drug use [J]. PLoS One, 2014, 9(2): e89324.
  • 5任德权, 张伯礼. 中药注射剂临床应用指南 [M]. 北京: 人民卫生出版社, 2011: 31-34.
  • 6医院处方点评管理规范(试行) [S]. 2010.
  • 7关于进一步加强中药注射剂生产和临床使用管理的通知 [S]. 2009.
  • 8Horowitz E, Bergman L C, Ashkenazy C, et al. Off-label use of sodium valproate for schizophrenia [J]. PLoS One, 2014, 9(3): e92573.
  • 9Gilhooley M. Commercial speech and off-label drug uses: what role for wide acceptance, general recognition and research incentives? [J]. Am J Law Med, 2011, 37(2/3): 258-277.
  • 10Meadows W A, Hollowell B D. 'Off-label' drug use: an FDA regulatory term, not a negative implication of its medical use [J]. Int J Impot Res, 2008, 20(2): 135-144.

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部